Suerie Moon
Cited by
Cited by
The political origins of health inequity: prospects for change
OP Ottersen, J Dasgupta, C Blouin, P Buss, V Chongsuvivatwong, J Frenk, ...
The Lancet 383 (9917), 630-667, 2014
Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola
S Moon, D Sridhar, MA Pate, AK Jha, C Clinton, S Delaunay, V Edwin, ...
The Lancet 386 (10009), 2204-2221, 2015
Making Technological Innovation Work for Sustainable Development
L Diaz Anadon, G Chan, AG Harley, K Matus, S Moon, SL Murthy, ...
Governance challenges in global health
J Frenk, S Moon
New England Journal of Medicine 368 (10), 936-942, 2013
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ...
The Lancet 393 (10178), 1331-1384, 2019
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
E Hoen, J Berger, A Calmy, S Moon
Journal of the International AIDS Society 14 (1), 15-15, 2011
A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries
B Waning, E Diedrichsen, S Moon
Journal of the International AIDS Society 13, 1-9, 2010
From sovereignty to solidarity: a renewed concept of global health for an era of complex interdependence
J Frenk, O Gómez-Dantés, S Moon
The Lancet 383 (9911), 94-97, 2014
A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
S Moon, E Jambert, M Childs, T von Schoen-Angerer
Globalization and Health 7, 1-11, 2011
The global health system: actors, norms, and expectations in transition
NA Szlezák, BR Bloom, DT Jamison, GT Keusch, CM Michaud, S Moon, ...
PLoS Medicine 7 (1), e1000183, 2010
Reimagining global health governance in the age of COVID-19
LO Gostin, S Moon, BM Meier
American Journal of Public Health 110 (11), 1615-1619, 2020
Fatal Imbalance: the crisis in research and development for drugs for neglected diseases
D Berman, D Smith, A Warpinski, S Moon, ...
Médecins Sans Frontičres Access to Essential Medicines Campaign and the …, 2001
Pricing of pharmaceuticals is becoming a major challenge for health systems
SG Morgan, HS Bathula, S Moon
Bmj 368, 2020
Toward a common secure future: four global commissions in the wake of Ebola
LO Gostin, O Tomori, S Wibulpolprasert, AK Jha, J Frenk, S Moon, ...
PLoS medicine 13 (5), e1002042, 2016
Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?
S Moon, J Bermudez, E 't Hoen
PLoS Medicine 9 (5), e1001218, 2012
Post-Ebola reforms: ample analysis, inadequate action
S Moon, J Leigh, L Woskie, F Checchi, V Dzau, M Fallah, G Fitzgerald, ...
Bmj 356, 2017
Global public goods for health: weaknesses and opportunities in the global health system
S Moon, JA Rřttingen, J Frenk
Health Economics, Policy and Law 12 (2), 195-205, 2017
Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
B Waning, M Kyle, E Diedrichsen, L Soucy, J Hochstadt, T Bärnighausen, ...
Globalization and Health 6, 1-19, 2010
Power in global governance: an expanded typology from global health
S Moon
Globalization and health 15 (Suppl 1), 74, 2019
Shared responsibilities for health: a coherent global framework for health financing. Final Report of the Centre on Global Health Security Working Group on Health Financing
J Rřttingen, T Ottersen, A Ablo, D Arhin-Tenkorang, C Benn, R Elovainio, ...
Chatham House, 2014
The system can't perform the operation now. Try again later.
Articles 1–20